Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-11-19 4:02 pm Purchase |
2021-11-18 | 13G | Cardiff Oncology, Inc. CRDF |
PFIZER INC PFE |
2,411,575 5.750% |
2,411,575 (New Position) |
Filing History |
| 2021-09-20 4:25 pm Purchase |
2021-09-13 | 13G | Arvinas, Inc. ARVN |
PFIZER INC PFE |
3,457,815 6.600% |
3,457,815 (New Position) |
Filing History |
| 2021-09-17 4:27 pm Unchanged |
2021-09-10 | 13D | Cerevel Therapeutics Holdings, Inc. CERE |
PFIZER INC PFE |
27,349,211 18.900% |
0 (Unchanged) |
Filing History |
| 2021-09-17 4:17 pm Unchanged |
2021-09-10 | 13D | Allogene Therapeutics, Inc. ALLO |
PFIZER INC PFE |
22,032,040 15.500% |
0 (Unchanged) |
Filing History |
| 2021-07-09 4:25 pm Purchase |
2021-06-30 | 13G | Spero Therapeutics, Inc. SPRO |
PFIZER INC PFE |
2,362,348 7.370% |
2,362,348 (New Position) |
Filing History |
| 2021-07-09 4:16 pm Unchanged |
2021-07-01 | 13D | Cerevel Therapeutics Holdings, Inc. CERE |
PFIZER INC PFE |
27,349,211 19.400% |
0 (Unchanged) |
Filing History |
| 2021-03-25 4:17 pm Sale |
2021-03-16 | 13G | Quince Therapeutics, Inc. QNCX |
PFIZER INC PFE |
2,056,377 7.000% |
-86,995 (-4.06%) |
Filing History |
| 2021-02-12 6:37 pm Purchase |
2020-12-31 | 13G | 4D Molecular Therapeutics, Inc. FDMT |
PFIZER INC PFE |
1,666,658 6.300% |
1,666,658 (New Position) |
Filing History |
| 2021-02-12 6:00 pm Purchase |
2020-12-31 | 13G | BioAtla, Inc. BCAB |
PFIZER INC PFE |
2,238,090 7.000% |
2,238,090 (New Position) |
Filing History |
| 2021-02-12 5:37 pm Sale |
2020-12-31 | 13G | Quince Therapeutics, Inc. QNCX |
PFIZER INC PFE |
2,143,372 7.300% |
-1,106,601 (-34.05%) |
Filing History |
| 2021-02-12 5:17 pm Purchase |
2020-12-31 | 13G | ContraFect Corporation CFRX |
PFIZER INC PFE |
22,316 6.400% |
22,316 (New Position) |
Filing History |
| 2021-02-12 5:08 pm Sale |
2020-12-31 | 13G | SpringWorks Therapeutics, Inc. SWTX |
PFIZER INC PFE |
4,583,047 9.400% |
-10,800 (-0.24%) |
Filing History |
| 2021-02-12 4:31 pm Sale |
2020-12-31 | 13G | Pfizer Inc. PFE |
STATE STREET CORP STT |
279,831,373 5.030% |
-28,599,376 (-9.27%) |
Filing History |
| 2021-02-12 4:28 pm Sale |
2020-12-31 | 13G | Morphic Holding, Inc. MORF |
PFIZER INC PFE |
1,265,635 4.100% |
-1,263,200 (-49.95%) |
Filing History |
| 2021-02-12 4:17 pm Sale |
2020-12-31 | 13G | Mersana Therapeutics, Inc. MRSN |
PFIZER INC PFE |
0 0.000% |
-2,209,631 (Position Closed) |
Filing History |
| 2021-02-10 11:40 am Sale |
2020-12-31 | 13G | Pfizer Inc. PFE |
The Vanguard Group | 447,958,747 8.060% |
-26,298,281 (-5.55%) |
Filing History |
| 2021-01-29 5:22 pm Sale |
2020-12-31 | 13G | Pfizer Inc. PFE |
BLACKROCK INC BLK |
396,973,512 7.100% |
-52,271,179 (-11.64%) |
Filing History |
| 2020-11-19 4:13 pm Purchase |
2020-11-10 | 13G | Homology Medicines, Inc. FIXX |
PFIZER INC PFE |
277,778 9.900% |
277,778 (New Position) |
Filing History |
| 2020-11-06 4:10 pm Purchase |
2020-10-27 | 13D | Cerevel Therapeutics Holdings, Inc. CERE |
PFIZER INC PFE |
27,349,211 21.500% |
27,349,211 (New Position) |
Filing History |
| 2020-08-06 4:22 pm Purchase |
2020-07-31 | 13G | ESSA Pharma Inc. EPIX |
PFIZER INC PFE |
1,675,000 6.000% |
1,675,000 (New Position) |
Filing History |